Sensorion Appoints Fred Chereau as CEO
Sensorion, a pioneering clinical-stage biotechnology company specialising in the development of novel therapies to restore, treat and prevent hearing loss disorders, on May 18th announced the appointment of Fred Chereau as Chief Executive Officer (CEO), effective June 1, 2026. Fred brings more than 30 years of leadership and operational experience across the biotechnology, pharmaceutical, and medical […]
Samsung Epis Holdings Launches Its New Investment Holding as Samsung Bioepis
Samsung Epis Holdings Co., Ltd. recently announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). Samsung Epis Holdings will be listed on Korea Exchange (KRX) on November 24, 2025, after the establishment of a new subsidiary company on November 14, 2025. Samsung […]
UVJC Launches Global Headquarters and R&D Center in Singapore
Universal Vapor Jet Corporation (UVJC), a wholly-owned subsidiary of Universal Display Corporation (UDC), recently announced the launch of its global headquarters and R&D center in Mapletree Hi-Tech Park Kallang Way, Singapore. The 8,000-square-foot facility includes the company’s global headquarters, its state-of-the-art research and development (R&D) center, laboratory, and prototype manufacturing space to support innovation and commercialization of its […]
Sai Life Sciences Opens Veterinary API Facility in Bidar, India
Sai Life Sciences, an innovator-focused Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on September 18 the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. The new facility […]
Avanzanite Bioscience Appoints Dr. Mark Bechter as SVP of Medical Affairs
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European speciality pharmaceutical company focused on rare diseases, announced on 10th September the appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs. As the sixth executive leadership hire of 2025, this appointment further strengthens Avanzanite’s “Champions League” team. It also underscores the company’s commitment to […]
Cosette Names Jeff Neubig as VP of Quality & Regulatory Affairs
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced on June 30th that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. In this critical role, Jeff will lead Cosette’s best-in-class quality and regulatory affairs organizations, maintaining the company’s rigorous quality standards and further establishing Cosette’s strong position as a respected […]
Aymeric de Gantès Named New CEO of Enginzyme
Enginzyme AB, a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology, announced on May 27th that it had appointed Aymeric de Gantès as CEO. Founder Karim Engelmark Cassimjee will develop a new position as Chief Innovation Officer. De Gantès comes to enginzyme from Ingredion, one of the leading multinational food-ingredients company, where he was […]
Pharmaceutical Automation and Digitalisation Congress (AUTOMA+ 2024)
Pharmaceutical Automation and Digitalisation Congress (AUTOMA+ 2024 | Zurich, Switzerland, 18-19 November) is an annual event where attendees showcase their case studies and connect with industry experts, all with the goal of promoting effective digital transformation. The closed-door format of the Congress ensures that only decision-makers and key specialists are going to be there. AUTOMA+ […]
Aptar Pharma and Pulmotree Collaborate to Develop and Promote Kolibri Non-Propellant Liquid Inhaler Platform
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, recently announced that it has entered into an exclusive collaboration agreement with PULMOTREE to lead the development and promotion of their Kolibri™ Non-Propellant Liquid Inhaler (NPLI) platform. As part of the agreement, Aptar Pharma will provide PULMOTREE with their full […]
Synplogen collaborates with Ginkgo Bioworks
Synplogen Co., a synthetic biology startup spun out of Kobe University’s Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy Biofoundry services, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a non-binding Memorandum of Understanding (“MOU”). Together, Synplogen […]
